Last reviewed · How we verify

Tetanus

Robert Krance · FDA-approved active Biologic ✓ Verified May 2026

Tetanus is a Biologic drug developed by Robert Krance. It is currently FDA-approved. Also known as: Tetanus Toxoid vaccine.

Tetanus is a bacterial infection caused by Clostridium tetani, characterized by muscle spasms that begin in the jaw and progress to the rest of the body. The spasms typically last for a few minutes and occur frequently for three to four weeks, with some spasms being severe enough to fracture bones.

At a glance

Generic nameTetanus
Also known asTetanus Toxoid vaccine
SponsorRobert Krance
ModalityBiologic
Therapeutic areaOther
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Tetanus

What is Tetanus?

Tetanus is a Biologic drug developed by Robert Krance.

Who makes Tetanus?

Tetanus is developed and marketed by Robert Krance (see full Robert Krance pipeline at /company/robert-krance).

Is Tetanus also known as anything else?

Tetanus is also known as Tetanus Toxoid vaccine.

What development phase is Tetanus in?

Tetanus is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing